[go: up one dir, main page]

WO2008118469A3 - Variantes génétiques associées à la restriction de la maladie vih - Google Patents

Variantes génétiques associées à la restriction de la maladie vih Download PDF

Info

Publication number
WO2008118469A3
WO2008118469A3 PCT/US2008/003964 US2008003964W WO2008118469A3 WO 2008118469 A3 WO2008118469 A3 WO 2008118469A3 US 2008003964 W US2008003964 W US 2008003964W WO 2008118469 A3 WO2008118469 A3 WO 2008118469A3
Authority
WO
WIPO (PCT)
Prior art keywords
variants associated
hiv disease
restriction
genetics
genetics variants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2008/003964
Other languages
English (en)
Other versions
WO2008118469A2 (fr
Inventor
David B Goldstein
Amalio Telenti
Jacques Fellay
Kevin V Shianna
Dongliang Ge
Barton F Haynes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite de Lausanne
Duke University
Original Assignee
Universite de Lausanne
Duke University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite de Lausanne, Duke University filed Critical Universite de Lausanne
Priority to CA002680834A priority Critical patent/CA2680834A1/fr
Priority to AU2008231305A priority patent/AU2008231305A1/en
Priority to EP08727164A priority patent/EP2121985A4/fr
Priority to JP2010500973A priority patent/JP2010522560A/ja
Publication of WO2008118469A2 publication Critical patent/WO2008118469A2/fr
Publication of WO2008118469A3 publication Critical patent/WO2008118469A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • AIDS & HIV (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La présente invention concerne, en général, le virus de l'immunodéficience humaine (VIH), et en particulier, des variantes génétiques associées à la restriction de la progression de la maladie VIH.
PCT/US2008/003964 2007-03-27 2008-03-27 Variantes génétiques associées à la restriction de la maladie vih Ceased WO2008118469A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA002680834A CA2680834A1 (fr) 2007-03-27 2008-03-27 Variantes genetiques associees a la restriction de la maladie vih
AU2008231305A AU2008231305A1 (en) 2007-03-27 2008-03-27 Genetics variants associated with HIV disease restriction
EP08727164A EP2121985A4 (fr) 2007-03-27 2008-03-27 Variantes génétiques associées à la restriction de la maladie vih
JP2010500973A JP2010522560A (ja) 2007-03-27 2008-03-27 Ｈｉｖ疾患制限に関連する遺伝的変異体

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US90727107P 2007-03-27 2007-03-27
US60/907,271 2007-03-27
US92943207P 2007-06-27 2007-06-27
US60/929,432 2007-06-27

Publications (2)

Publication Number Publication Date
WO2008118469A2 WO2008118469A2 (fr) 2008-10-02
WO2008118469A3 true WO2008118469A3 (fr) 2008-12-24

Family

ID=39789200

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2008/003964 Ceased WO2008118469A2 (fr) 2007-03-27 2008-03-27 Variantes génétiques associées à la restriction de la maladie vih

Country Status (5)

Country Link
EP (1) EP2121985A4 (fr)
JP (1) JP2010522560A (fr)
AU (1) AU2008231305A1 (fr)
CA (1) CA2680834A1 (fr)
WO (1) WO2008118469A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105316417B (zh) * 2015-11-27 2018-11-30 北京泱深生物信息技术有限公司 Znrd1基因及其表达产物作为颅内动脉瘤的诊治靶标
MX2019007012A (es) * 2016-12-14 2019-11-28 Merck Sharp & Dohme Marcadores geneticos humanos asociados con la respuesta a tratamientos que se dirigen a la toxina b de clostridium difficile.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005332331A1 (en) * 2004-11-26 2006-12-07 Board Of Regents, The University Of Texas System Methods and compositions for correlating CCL3L1/CCR5 genotypes with disorders

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
FELLAY ET AL.: "A whole-genome association study of major determinant for host control of HIV-1", SCIENCE, vol. 317, no. 5840, August 2007 (2007-08-01), pages 944 - 947, XP002551832 *
See also references of EP2121985A4 *

Also Published As

Publication number Publication date
CA2680834A1 (fr) 2008-10-02
EP2121985A2 (fr) 2009-11-25
JP2010522560A (ja) 2010-07-08
AU2008231305A1 (en) 2008-10-02
EP2121985A4 (fr) 2011-01-05
WO2008118469A2 (fr) 2008-10-02

Similar Documents

Publication Publication Date Title
IL281111A (en) Preparations for imparting resistance to viral diseases in social insects, and their use
USD624989S1 (en) Single-handle deck-mount faucet
USD660055S1 (en) Seating unit
USD660054S1 (en) Seating unit
USD625507S1 (en) Folding canopy
WO2008045238A3 (fr) Peptides antiviraux hélicoïdaux courts thérapeutiques stabilisés
EP1848837A4 (fr) Stabilite de verre amelioree, capacite de formation de verre, et affinage microstructurel
WO2011012316A3 (fr) Arn ayant une combinaison de nucléotides non modifiés et modifiés pour l'expression protéique
WO2008014200A3 (fr) Compositions de cyclosporine
USD697565S1 (en) Physical exerciser
WO2008151032A3 (fr) Ensembles et procédés comprenant des produits géniques de m. smithii
USD644455S1 (en) Table
WO2011049914A3 (fr) Peptides anti-vih et méthodes d'utilisation
WO2008088747A3 (fr) Procédé de surveillance d'une infection par le vih
WO2009099467A3 (fr) Compositions de cyclosporine
USD687556S1 (en) BOXER'S fracture brace
USD675397S1 (en) Pair of sleeves
WO2012037116A3 (fr) Variations génétiques communes et rares associées à une immunodéficience commune variable (icv) et procédés d'utilisation de celles-ci pour le traitement et le diagnostic de cet état
WO2010046061A3 (fr) Préparations cosmétiques et/ou pharmaceutiques
WO2010064822A2 (fr) Lutte efficace contre une maladie virale des plantes avec des souches de pseudomonas oleovorans
WO2008033500A3 (fr) Vaccins à base de glucides contre le vih
USD628895S1 (en) Bottle
WO2008118469A3 (fr) Variantes génétiques associées à la restriction de la maladie vih
WO2009128911A3 (fr) Variants genetiques associes a la limitation de la maladie a vih
WO2008152252A3 (fr) Peptides rumc présentant une activité antimicrobienne

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08727164

Country of ref document: EP

Kind code of ref document: A2

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
ENP Entry into the national phase

Ref document number: 2680834

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 2010500973

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2008727164

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2008231305

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2008231305

Country of ref document: AU

Date of ref document: 20080327

Kind code of ref document: A

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)